通过导管修复中门的成本比较:PASCAL与MitraClip在现实环境中的比较
Jean Marc Haurand1, Jafer Haschemi1, Daniel Oehler1
1Department of Cardiology, Pulmonology and Vascular Medicine, University Hospital Düsseldorf, Medical Faculty of the Heinrich Heine University Düsseldorf, Moorenstr. 5, 40225, Düsseldorf, Germany.
BMC health services research
|September 4, 2023
概括
跨导管端到端维修 (TEER) 的成本对于Pascal和MitraClip系统来说是相似的,由设备费用驱动. 由于更长的住院时间,并发症增加了成本,突出了流程优化机会.
科学领域:
- 心血管干预 心血管干预
- 卫生经济学 卫生经济学
- 医疗设备分析 医疗设备分析
背景情况:
- 伴心回需要先进的治疗选择.
- 过导管边缘到边缘修复 (TEER) 提供了一种不那么侵入性的方法.
- 对医疗保健提供者来说,比较不同TEER系统的成本至关重要.
研究的目的:
- 为了进行一项临床过程成本分析,对关透导管边缘到边缘修复 (M-TEER).
- 评估和比较与MitraClip和PASCAL维修系统相关的即将发生的成本.
- 确定M-TEER程序中的关键成本驱动因素和并发症的财务影响.
主要方法:
- 预期招募107名接受PASCAL或MitraClipM-TEER的患者.
- 在手术和住院期间的住院费用的比较.
- 追溯分析716个M-TEER程序,以评估并发症成本.
- 评估导管实验室材料和一般医院费用.
主要成果:
- 前性研究:在PASCAL (25,414欧元) 和MitraClip (25,633欧元) 组之间,总住院费用是可比的.
- 设备成本是主要的材料支出,在两种系统中都是相似的.
- 追溯分析:M-TEER并发症不常见,但成本显著增加,主要是由于延长住院治疗.
结论:
- 由设备成本驱动的材料支出是M-TEER的主要成本因素.
- 帕斯卡和MitraClip系统显示了类似的患者治疗成本.
- 尽量减少与M-TEER相关的并发症对于降低成本至关重要,强调过程改进.
相关概念视频
Mitral Stenosis III: Medical Management
12
Mitral stenosis, a condition marked by the narrowing of the mitral valve, necessitates an integrated approach for effective management. This approach includes preventative measures, medical therapy, and surgical interventions to reduce symptoms and prevent complications.PreventionPrevention of mitral stenosis primarily focuses on reducing the incidence of bacterial infections, particularly streptococcal infections, which can lead to rheumatic fever and subsequent valvular damage. Timely...
12
Mitral Regurgitation III: Medical Management
18
Mitral regurgitation (MR) is characterized by retrograde blood circulation from the left ventricle into the left atrium due to inadequate mitral valve closure. The severity of the condition, symptoms, and underlying cause determine treatment strategies.Monitoring and Pharmacological TreatmentPatients with mild to moderate MR typically do not need immediate intervention but regular monitoring to assess progression and guide treatment. Patients with mild MR should have an echocardiogram every 3-5...
18
Mitral Valve Prolapse II: Assessment and Management
21
IntroductionA range of clinical features characterizes Mitral Valve Prolapse (MVP), but it is important to note that many individuals with MVP are asymptomatic and may remain so throughout their lives. For those who do exhibit symptoms, the following are the key clinical features:Palpitations: This is a common symptom where individuals feel an irregular or rapid heartbeat. Palpitations in MVP are often due to arrhythmias such as premature ventricular contractions or supraventricular...
21
Mitral Stenosis II: Clinical features and Diagnostic Tests
22
Mitral stenosis is a heart condition in which the mitral valve, which allows blood to flow from the left atrium to the left ventricle, becomes narrowed or stenotic. This narrowing hinders blood flow and leads to clinical symptoms requiring specific medical evaluations and management strategies. The following overview outlines the clinical symptoms, assessments, diagnostic findings, prevention methods, and treatments for mitral stenosis.Clinical ManifestationsDyspnea (shortness of breath): This...
22
Mitral Regurgitation I: Introduction
16
Mitral regurgitation is characterized by the backward circulation of blood from the left ventricle to the left atrium during systole, a phase of the cardiac cycle when the heart contracts and pumps blood out of the chambers. This abnormal flow occurs primarily due to the dysfunction of the mitral valve or its supporting structures, which include the mitral leaflets, chordae tendineae, annulus, and papillary muscles.Etiology and Mechanisms:Primary Mitral Regurgitation: This type arises from...
16
Mitral Regurgitation II: Clinical Features and Diagnostic Tests
22
Mitral regurgitation (MR) is a valvular heart disorder in which the mitral valve fails to close tightly, allowing blood to leak backward into the heart. Understanding the clinical manifestations, assessment, diagnostic findings, and medical management of MR is crucial to effectively managing affected patients.Clinical Manifestations of Mitral RegurgitationMitral regurgitation can be acute or chronic, each presenting differently and requiring different approaches:1. Acute Mitral...
22


